期刊文献+

N-cad和PCNA在胃癌组织中的表达及临床意义 被引量:1

Clinical signif icance of expression of neural cadherin and proliferating cell nuclear antigen in gastric carcinoma
下载PDF
导出
摘要 目的:研究神经性钙粘素(N-cad)和增殖细胞核抗原(PCNA)蛋白在胃癌组织中的表达及其临床意义.方法:选择手术切除的胃癌组织标本(n=79)为试验组,胃癌旁组织(n=45),以及正常胃黏膜组织(n=19)为对照组.应用免疫组织化学法检测胃癌组织、癌旁组织和正常组织中的N-cad和PCNA基因编码蛋白的表达情况,用SPSS13.0统计软件对N-cad和PCNA蛋白的表达差异及其与患者的临床病理特征进行统计学分析.结果:N-cad和PCNA蛋白在胃癌中阳性表达率分别为78.5(62/79)和88.6(70/79),与癌旁组织(71.1,80)比较无明显差异,但二者与对照组(10.5,15.8)比较有显著差异,组间比较有明显统计学差异(P<0.01).在试验组中,N-cad和PCNA蛋白表达与患者的年龄、性别、类型及是否淋巴结转移均无明显统计学差异,而与肿瘤的分化程度及TNM分期有关(N-cad:62.5%vs89.4%,64.5%vs87.5%;PCNA:83.3%vs95.7%,77.4%vs95.8%,均P<0.05).结论:N-cad和PCNA蛋白在胃癌组织中表达明显上调,二者呈正相关,可联合作为评估胃癌恶性生物学行为和预后指标. AIM: To investigate the expression of neural cadherin (N-cad) and proliferating cell nuclear antigen (PCNA) proteins in gastric carcinoma and to analyze their clinical signif icance. METHODS: Seventy-nine surgical specimens of gastric cancer, 45 paracancerous tissue specimens, and 19 normal gastric mucosal tissue specimens were used in this study. N-cad and PCNA protein expression in these specimens was examined by immunohistochemistry. The correlation between the expression of N-cad and PCNA proteins and clinicopathologic parameters of gastric carcinoma was analyzed. RESULTS: The rates of N-cad and PCNA protein overexpression in gastric carcinoma were78.5% (62/79) and 88.6 (70/79), respectively. Although there were no statistical signifi cances in the rates of N-cad and PCNA protein overex-pression between gastric carcinoma and paracancerous tissue, they were signifi cantly higher than those in normal control tissue (both P 0.01). N-cad and PCNA protein overexpression was associated with tumor differentiation and TNM stage (N-cad: 62.5% vs 89.4%, 64.5% vs 87.5%; PCNA: 83.3% vs 95.7%, 77.4% vs 95.8%, all P 0.05), but not with sex, age, tumor type or lymph node metastasis (all P 0.05). CONCLUSION: Up-regulation of N-cad and PCNA protein expression was observed in gastric carcinoma. Detection of N-cad and PCNA protein expression can be used to evaluate malignant biological behavior and prognosis of gastric cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第34期3477-3482,共6页 World Chinese Journal of Digestology
基金 徐州市科技计划发展基金资助项目 No.XF10C079~~
关键词 神经型钙粘素 增殖细胞核抗原 胃癌组织 癌旁组织 免疫组织化学 Neural cadherin Proliferating cell nuclear antigen Gastric cancer Paracancerous tissue Immunohistochemistry
  • 相关文献

参考文献18

  • 1Lascombe I,Clairotte A,Fauconnet S,Bernardini S,Wallerand H,Kantelip B,Bittard H.N-cadherinas a novel prognostic marker of progression in su-perficial urothelial tumors.Clin Cancer Res2006;12:2780-2787.
  • 2Alexander NR,Tran NL,Rekapally H,Summers CE,Glackin C,Heimark RL.N-cadherin gene ex-pression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.Cancer Res2006;66:3365-3369.
  • 3Hatta K,Takeichi M.Expression of N-cadherin ad-hesion molecules associated with early morphoge-netic events in chick development.Nature1986;320:447-449.
  • 4Volk T,Geiger B.A135-kd membrane protein ofintercellular adherens junctions.EMBO J1984;3:2249-2260.
  • 5Andersson AM,Edvardsen K,Skakkebaek NE.Ex-pression and localization of N-and E-cadherin in the human testis and epididymis.Int J Androl1994;17:174-180.
  • 6Cavallaro U.N-cadherin as an invasion promoter:a novel target for antitumor therapy Curr Opin In-vestig Drugs2004;5:1274-1278.
  • 7Mosnier JF,Kandel C,Cazals-Hatem D,Bou-Hanna C,Gournay J,Jarry A,Laboisse CL.N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.Mod Pathol2009;22:182-190.
  • 8Mariotti A,Perotti A,Sessa C,Rüegg C.N-cadherin as a therapeutic target in cancer.Expert Opin Inves-tig Drugs2007;16:451-465.
  • 9Giussani P,Brioschi L,Bassi R,Riboni L,Viani P.Phosphatidylinositol3-kinase/AKT pathway regulates the endoplasmic reticulum to golgi traf-fic of ceramide in glioma cells:a link between lipid signaling pathways involved in the control of cell survival.J Biol Chem2009;284:5088-5096.
  • 10Perotti A,Sessa C,Mancuso A,Noberasco C,Cresta S,Locatelli A,Carcangiu ML,Passera K,Braghetti A,Scaramuzza D,Zanaboni F,Fasolo A,Capri G,Miani M,Peters WP,Gianni L.Clinical and phar-macological phase I evaluation of Exherin(ADH-1),a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours.Ann Oncol2009;20:741-745.

二级参考文献29

共引文献52

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部